About Partners Intelligence Log in →
Connecting Israeli Defense Tech to US Needs
Log in

Neteera

Contactless radar-on-chip continuous vital-signs monitoring

Israel
51-200

Latest event found: 1 Oct 2026 · 19 days ago

Vitality Radar

57
Current
6M History
Industry
Updated 7 days ago

Pillar Analysis

Presence
The analyst’s view of digital footprint. Shown for context; not part of the score.
72
Business
Dated funding, customer wins, partnerships and acquisitions made, less down rounds, litigation and regulatory action.
76
Innovation
Dated product launches and regulatory clearances, less products retired.
insufficient evidence
Pulse
Direction: dated events in the last 90 days against the 90 before. 50 is flat.
32
Capacity
Dated hiring, leadership hires, expansion and certifications, less layoffs, departures and closures.
insufficient evidence

Strategic Assessment

Strategic Vector

Neteera is extending its FDA-cleared contactless radar monitoring from post-acute care into broader enterprise and U.S. federal healthcare markets through channel partnerships and clinical validation. The strategy emphasizes ambient sensing, remote patient monitoring, and early deterioration detection rather than wearable-based care.

Efficiency Ratio

The company shows strong technology-to-market efficiency by converting a relatively compact organization into clinical evidence, international deployments, regulatory positioning, and enterprise distribution partnerships, although public revenue and hiring data remain limited.

Evidence Signals

Customer Win MEDIUM IMPACT LOW CONF 1 Oct 2026

DRK Care Home in Chemnitz deployed Neteera’s radar-based continuous patient monitoring system.

View source Chemnitz, Germany
Partnership HIGH IMPACT MEDIUM CONF 3 Jun 2026

Neteera partnered with GlobalMed and Smart Meter to integrate contactless radar monitoring into GlobalMed’s eNcounter platform, with GlobalMed serving as the exclusive reseller for the U.S. federal government market.

View source United States
Partnership MEDIUM IMPACT MEDIUM CONF 17 Feb 2026

CCN Health partnered with Neteera to include its FDA-cleared monitoring devices in turnkey remote patient monitoring and care management programs.

View source

About
Israeli medical-device company (Jerusalem-based Neteera Technologies Ltd.; US entity Neteera US Inc. in Lewes, Delaware), founded in 2015 by a group of high-tech veterans including CEO Isaac Litman (former CEO of Mobileye Aftermarket). Its micro-radar-on-chip (116–123 GHz CMOS) plus AI algorithms sense the skin's micro-movements to continuously measure vital signs — heart rate, respiratory rate, HRV, tidal volume — contactlessly through clothing and bedding at up to 1.5 m, with no cameras or microphones. FDA-cleared and CE-certified. Used in nursing homes, home care, hospitals and telemedicine; applicable to unobtrusive casualty/patient monitoring in the C12 prolonged-field-care thread. Defense relevance is commercial-first.
Tags
#radar #contactless #vitals #rpm #cmos #sensoronchip #fda #monitoring #dualuse

Suggest an edit

Footer

Connecting Israeli Defense Tech to US Needs

Powered by Meschonomy

Terms Privacy Contact